An autopsy case of immune-related severe colitis due to long-term use of nivolumab in a patient with non-small cell lung cancer

Immune checkpoint inhibitors (ICIs) have been developed as cornerstones of cancer therapy, but the growing use of ICIs has induced immune-related adverse effects (irAEs). Immune-related colitis, which is one of the most common irAEs, generally occurs 2–4 months after ICI treatment initiation and can...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujikawa, Masashi, Tajiri, Tomoko, Takemura, Masaya, Nakao, Kenju, Yamamoto, Sayaka, Takeda, Norihisa, Fukumitsu, Kensuke, Fukuda, Satoshi, Kamemitsu, Yoshihiro, Uemura, Takehiro, Ohkubo, Hirotsugu, Maeno, Ken, Ito, Yutaka, Oguri, Tetsuya, Niimi, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385684/
https://www.ncbi.nlm.nih.gov/pubmed/35993006
http://dx.doi.org/10.1016/j.rmcr.2022.101720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385684/
https://www.ncbi.nlm.nih.gov/pubmed/35993006
http://dx.doi.org/10.1016/j.rmcr.2022.101720

Ejemplares similares